Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

Clinical trial NCT02352753 · TERMINATED

Trial details

NCT number: NCT02352753
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteogenesis Imperfecta

Start date: 2015-06-24
Primary completion: 2022-03-26
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.